Petosemtamab (Anti-GPR49 / LGR5)

Petosemtamab (Anti-GPR49 / LGR5) is an monoclonal antibody that targets GPR49/LGR5. It blocks the appearance of metastases and slows the growth of primary tumors in experimental cancer models. Petosemtamab can be used in the research of solid tumors, such as head and neck squamous cell carcinoma (HNSCC), metastatic colorectal cancer (CRC). MW: 145.5 KD.
Supplier Selleck Chemicals
Product # A2474
Sku # A2474-1mg*25
Pricing 1mg*25, $4170.00
Feedback